Telecom Equipment company GTL Infrastructure announced Q4FY26 & FY26 results Financial Highlights: Revenue from Operations for Q4FY26 stood at Rs 33,036 lakh, a decrease of 5.77% QoQ from Rs 35,059 lakh in Q3FY26 and a decrease of 1.98% YoY compared to Rs 33,702 lakh in Q4FY25. Total Income for Q4FY26 was Rs 34,543 lakh, down 3.72% QoQ from Rs 35,876 lakh and an increase of 1.44% YoY from Rs 34,051 lakh in Q4FY25. The Company reported a Net Profit of Rs 1,18,558 lakh for Q4FY26, marking a significant turnaround from a profit of Rs 1,958 lakh in Q3FY26 and a loss of Rs 24,889 lakh in Q4FY25. This was primarily driven by exceptional items. Total Comprehensive Income for Q4FY26 reached Rs 1,18,641 lakh, compared to Rs 1,968 lakh in Q3FY26 and a comprehensive loss of Rs 24,893 lakh in Q4FY25. For FY26, Revenue from Operations was Rs 1,37,197 lakh, representing a growth of 2.08% YoY over Rs 1,34,407 lakh in FY25. Total Income for FY26 stood at Rs 1,41,907 lakh, up 3.91% YoY compared to Rs 1,36,569 lakh in FY25. Annual Net Profit for FY26 was Rs 77,926 lakh, showing a turnaround from a loss of Rs 87,515 lakh reported in FY25. Total Comprehensive Income for FY26 was Rs 78,028 lakh, compared to a comprehensive loss of Rs 87,566 lakh in the previous year. Basic and Diluted Earnings Per Share (EPS) for Q4FY26 stood at Rs 0.91, and For FY26, it stood at Rs 0.60. Business Highlights: Segment Performance: The Company is predominantly in the business of providing "Telecom Towers" on a shared basis in India. There are no separate reportable business segments. One-Time Settlement (OTS): During the year, the Company reached separate OTS sanctions with two secured lenders, settling all dues and disputes. Consequent to this, legal proceedings before the Debt Recovery Tribunal (DRT) and a petition before the National Company Law Tribunal (NCLT) have been withdrawn. Exceptional Items: The Company recorded a net exceptional gain of Rs 1,19,823 lakh during FY26. This includes Rs 93,496 lakh arising from OTS/NS agreements and Rs 26,327 lakh (net) towards the reversal of provision following an amicable settlement of a vendor claim. Convertible Bonds: As of March 31, 2026, the Company has outstanding Compulsorily Convertible Bonds (B1, B2, and B3). These instruments are convertible into equity shares, which will result in the issuance of 17,97,66,251 shares against B1, 24,40,80,848 shares against B2, and 6,69,68,994 shares against B3. Foreign Exchange Impact: An exchange loss of Rs 3,892 lakh for the quarter and Rs 7,276 lakh for the year was recognized due to rate fluctuations on interest and principal payable on foreign currency borrowings. Result PDF
Healthcare Facilities company Indraprastha Medical Corporation announced Q4FY26 & FY26 results Financial Highlights: Revenue from Operations: For Q4FY26, revenue stood at Rs 364.81 crore, representing a decrease of 1.83% QoQ from Rs 371.61 crore in Q3FY26 and an increase of 9.31% YoY from Rs 333.75 crore in Q4FY25. For FY26, revenue reached Rs 1,482.51 crore compared to Rs 1,356.36 crore in FY25, marking a growth of 9.30% YoY. Total Income: For Q4FY26, total income was Rs 372.14 crore, a marginal decrease of 1.75% QoQ from Rs 378.76 crore and an increase of 9.42% YoY from Rs 340.10 crore in Q4FY25. The annual total income for FY26 stood at Rs 1,511.26 crore, reflecting a 9.59% YoY growth from Rs 1,379.01 crore in FY25. Profit After Tax (PAT): For Q4FY26, the company reported a PAT of Rs 41.70 crore, showing an increase of 1.71% QoQ from Rs 41.00 crore in Q3FY26 and an increase of 1.68% YoY from Rs 41.01 crore in Q4FY25. The annual PAT for FY26 reached Rs 183.62 crore, representing a growth of 14.06% YoY compared to Rs 160.99 crore in FY25. Earnings Per Share (EPS): The basic and diluted EPS for FY26 was Rs 20.03, up from Rs 17.56 in FY25. Business Highlights: Dividend: The Board of Directors has recommended a final dividend of 40% i.e., Rs 4.00 per equity share (face value of Rs 10 each) for FY26. Segment Performance: The Company operates in a single segment, Healthcare. Accordingly, there are no additional disclosures to be made under Ind AS 108 on Operating Segments. Corporate Structure: As of March 31, 2026, the Company does not have any subsidiary, associate, or joint venture companies. Regulatory Compliance: The Company confirmed that it does not fall under the criteria of "Large Corporate (LC)" as specified by SEBI circulars. Labour Code Impact: The Government of India has consolidated 29 existing labour legislations into four Labour Codes. The Company has accounted for the incremental estimated liability in the statement of audited financial results for the current year. Result PDF
Capital Markets company Master Trust announced Q4FY26 & FY26 results Consolidated Financial Highlights: Total Revenue from Operations For Q4FY26, consolidated revenue stood at Rs 1,806.1 million, representing an increase of 32.10% QoQ from Rs 1,367.2 million in Q3FY26 and a growth of 48.06% YoY compared to Rs 1,219.8 million in Q4FY25. For the full year FY26, consolidated revenue was Rs 5,758.5 million, a marginal decline of 1.39% compared to Rs 5,839.4 million in FY25. Profit Before Tax (PBT): For Q4FY26, consolidated PBT was Rs 487.3 million, up 9.16% QoQ from Rs 446.4 million in Q3FY26 and up 30.22% YoY from Rs 374.2 million in Q4FY25. For the full year FY26, consolidated PBT reached Rs 1,724.8 million compared to Rs 1,787.2 million in FY25, a decrease of 3.49%. Net Profit After Tax (PAT): For Q4FY26, consolidated PAT (attributable to the owner) was Rs 347.9 million, a growth of 22.63% QoQ from Rs 283.7 million in Q3FY26 and a significant increase of 190.40% YoY from Rs 119.8 million in Q4FY25. For the full year FY26, consolidated PAT stood at Rs 1,222.2 million, reflecting a growth of 5.71% compared to Rs 1,156.2 million in FY25. Standalone Financial Highlights Total Income: For Q4FY26, standalone total income was Rs 83.0 million, a decrease of 14.87% QoQ from Rs 97.5 million in Q3FY26, and an increase of 65.67% YoY from Rs 50.1 million in Q4FY25. For the full year FY26, standalone total income grew by 45.60% to Rs 291.5 million from Rs 200.2 million in FY25. Profit Before Tax (PBT): For Q4FY26, standalone PBT was Rs 55.8 million, down 20.85% QoQ from Rs 70.5 million in Q3FY26, but up 108.21% YoY from Rs 26.8 million in Q4FY25. For the full year FY26, standalone PBT was Rs 197.9 million, a growth of 94.98% compared to Rs 101.5 million in FY25. Net Profit After Tax (PAT): For Q4FY26, standalone PAT was Rs 41.5 million, representing a growth of 27.69% QoQ from Rs 32.5 million in Q3FY26, and a surge of 1,876.19% YoY from Rs 2.1 million in Q4FY25. For the full year FY26, standalone PAT reached Rs 122.3 million, up 68.46% from Rs 72.6 million in FY25. Business Highlights Consolidated Segment Revenue Performance (FY26): Broking & Allied: Revenue increased to Rs 5,377.5 million compared to Rs 5,236.0 million in FY25. Interest: Revenue stood at Rs 120.4 million compared to Rs 126.0 million in FY25. Portfolio Management Services: Revenue decreased to Rs 121.7 million from Rs 195.3 million in FY25. Insurance Broking: Revenue grew to Rs 52.6 million from Rs 40.7 million in FY25. Investment/Trading in Securities/Land & others: Revenue was Rs 86.3 million compared to Rs 241.4 million in FY25. Consolidated Segment Result Performance (FY26): Broking & Allied: Result stood at Rs 1,561.8 million vs Rs 1,469.4 million in FY25. Insurance Broking: Result significantly improved to Rs 36.0 million vs Rs 21.3 million in FY25. Portfolio Management Services: Result declined to Rs 14.0 million from Rs 30.2 million in FY25. Strategic Decision on Mutual Funds: The Board was intimated that Master Capital Services Limited, a Wholly Owned Subsidiary Company, had received In-principle approval from SEBI for sponsoring/setting up of mutual funds. However, the company has decided to defer the same for the time being. Directorate Changes: The Board approved the proposal for the appointment of Mr. Puneet Singhania and Mr. Jashanjyot Singh Arora as Additional Directors, subject to receiving prior approval from the Reserve Bank of India. Internal Audit: Re-appointment of M/s Romesh K. Aggarwal & Associates, Chartered Accountants, as the Internal Auditor of the Company for the Financial Year 2026-2027 was approved. Result PDF
Household Appliances company Stove Kraft announced Q4FY26 & FY26 results Financial Highlights: Revenue from operations: For Q4FY26, the company reported revenue of Rs 4,145.23 million, representing a growth of 9.55% QoQ from Rs 3,783.74 million in Q3FY26 and a growth of 32.44% YoY compared to Rs 3,129.92 million in Q4FY25. For FY26 , revenue stood at Rs 16,074.24 million, an increase of 10.87% YoY from Rs 14,498.17 million in FY25. Total Income: The total income for Q4FY26 was Rs 4,088.56 million, up 8.60% QoQ from Rs 3,764.73 million and up 30.09% YoY from Rs 3,142.97 million. For FY26 , total income reached Rs 15,990.47 million, a 10.26% increase YoY compared to Rs 14,502.08 million in FY25. Profit Before Tax (PBT): PBT for Q4FY26 stood at Rs 50.76 million, showing a slight decline of 6.17% QoQ from Rs 54.10 million in Q3FY26, but a significant increase of 366.54% YoY from Rs 10.88 million in Q4FY25. Annual PBT for FY26 was Rs 509.83 million, growing by 4.50% YoY from Rs 487.88 million. Net Profit (PAT): The company recorded a Net Profit of Rs 60.51 million in Q4FY26, marking a growth of 45.95% QoQ from Rs 41.46 million and an increase of 317.89% YoY from Rs 14.48 million in Q4FY25. For FY26 , PAT reached Rs 419.91 million, a growth of 9.05% YoY from Rs 385.05 million. Total Comprehensive Income: For FY26, the total comprehensive income was Rs 422.47 million, compared to Rs 382.88 million in FY25. Earnings Per Share (EPS): Basic and diluted EPS for FY26 stood at Rs 12.69, compared to Rs 11.65 (Basic) and Rs 11.64 (Diluted) in FY25. Business Highlights: Segment Performance: The company operates in a single reportable segment, which is Kitchen and Home Appliances. Dividend: The Board of Directors recommended a final dividend of Rs 3.50 per equity share (35%) of face value Rs 10 each for FY26. Management Change: The company accepted the resignation of Mr. Ramakrishna Pendyala from the position of Chief Financial Officer effective 15 May 2026. Mr. Subhadeep Pal was appointed as the new Chief Financial Officer with effect from 16 May 2026. Employee Stock Options: The Board approved an amendment to the Stovekraft Employee Stock Option Plan 2018 to increase the ESOP pool from 8,13,000 to 10,25,000 stock options. Additionally, 46,915 stock options were granted to eligible employees during the period. Store Strategy and One-time Gain: Following a reassessment of estimates relating to right-of-use assets and lease liabilities under Ind AS 116 (due to store consolidations and closures), the company recorded a one-time gain of Rs 15.71 million under "Other gains / (losses) - net" during FY26. Labour Code Impact: Due to the notification of new Labour Codes by the Government of India, the company recognized an increase in gratuity and compensated benefits, resulting in an incremental past service cost of Rs 12.01 million during the year. Result PDF
Electric Utilities company Tata Power Company announced Q4FY26 & FY26 results Financial Highlights: Revenue: For Q4FY26, Revenue stood at Rs 15,962 crore, marking a decrease of 8% YoY from Rs 17,328 crore in Q4FY25. For FY26, Revenue reached Rs 63,681 crore, down 1% YoY compared to Rs 64,502 crore in FY25. EBITDA: Q4FY26 EBITDA grew by 10% YoY to Rs 4,216 crore, up from Rs 3,829 crore in Q4FY25. For FY26, EBITDA rose to Rs 16,090 crore, representing an 11% YoY increase from Rs 14,468 crore in FY25. Profit After Tax (PAT): Reported PAT for Q4FY26 was Rs 1,416 crore, an increase of 8% YoY from Rs 1,306 crore in Q4FY25. The annual reported PAT for FY26 reached an all-time high of Rs 5,118 crore, reflecting a 7% YoY growth from Rs 4,775 crore in FY25. Business Highlights: Dividend: The Board recommended a dividend of Rs 2.50 per equity share for FY26, compared to Rs 2.25 per equity share for FY25. Power Supply: In FY26, Tata Power supplied 49.52 billion units of electricity to the grid, and its Discoms supplied approximately 47.92 billion units to consumers. Renewable Execution: Tata Power Renewable Energy Ltd (TPREL) crossed 10 GW of cumulative Solar EPC execution and commissioned 2.5 GW of renewable capacity in FY26. The company’s renewable portfolio now stands at 11.6 GW, which includes an under-construction capacity of 5.1 GW. Solar Manufacturing Investment: The TPREL Board approved an investment of approximately Rs 6,500 crore in a photovoltaic ingot and wafer manufacturing facility of 10 GW (in two phases of 5 GW each). Mundra Resolution: The Mundra SPPA was successfully signed with GUVNL, with the Ministry of Power issuing directions to permit plant operations from 1st April 2026 to 30th June, 2026. Regional Partnerships: A first disbursement of Rs 500 crore was completed from PFC for the 600 MW Khorlochhu Hydro Power Project. Additionally, the Royal Government of Bhutan and the World Bank Group signed a financing agreement totaling USD 515 million for the 1,125 MW Dorjilung Hydroelectric Power Project, where Tata Power holds a 40% equity stake. EV Infrastructure: The EV Charging business surpassed 2 lakh home EV charger installations, and the EZ Charge mobile application crossed 5 lakh registered users. The nationwide charging network grew to over 7,000 public and semi-public charging points. Segment-wise Performance: Core Business: Delivered strong performance with Revenue growth of 13%, EBITDA growth of 27%, and PAT growth of 34% YoY in FY26. Renewables Business: PAT stood at Rs 406 crore in Q4FY26. For FY26, PAT rose to Rs 1,994 crore, up 59% YoY. FY26 EBITDA for the cluster increased by 44% to Rs 6,228 crore. Solar Cell and Module Manufacturing (TP Solar): PAT grew to Rs 265 crore, up 40% YoY in Q4FY26. FY26 PAT rose to Rs 857 crore, up 103% YoY. The segment achieved a Revenue of Rs 6,968 crore in FY26 with the production of 3,825 MW of modules and 3,759 MW of cells. Rooftop Solar: PAT grew to Rs 186 crore, up 94% YoY in Q4FY26. For the full year, FY26 PAT rose to Rs 499 crore, up 150% YoY. Tata Power Solaroof crossed 3.7 lakh installations (cumulative installed capacity beyond 4.8 GWp), with FY26 contributing 1.7 GWp. Transmission & Distribution (T&D;): PAT stood at Rs 949 crore in Q4FY26, up 54% YoY. For FY26, PAT rose to Rs 2,978 crore, up 49% YoY. The transmission portfolio now stands at 7,403 Ckm. Odisha DISCOMs: PAT grew to Rs 304 crore in Q4FY26, up 11% YoY. FY26 PAT rose to Rs 809 crore, up 84% YoY. The segment reported a Revenue of Rs 19,980 crore in FY26. Generation Business: Maithon Power Limited delivered a revenue of Rs 3,095 crore and PAT of Rs 404 crore in FY26. Praveer Sinha, CEO & Managing Director, Tata Power, said: "This quarter and year reflect our sustained focus on creating long-term value through disciplined growth, operational excellence and strategic partnerships. The addition of new clean energy assets, steady progress in TBCB projects, continued improvement in Distribution businesses in Odisha, Delhi & Mumbai and strengthening of cross-border regional energy collaboration, underscore our commitment to building a more resilient energy future. As electricity demand continues to rise and peak requirements are projected to reach 270 GW this year, energy security and reliability remain critical priorities. Our focus on rooftop solar solutions, manufacturing-linked self-reliance and deeper backward integration will play a key role in enabling dependable and future-ready energy systems, driving Tata Power’s growth. Aligned with India’s clean energy ambitions, we continue to strengthen our capabilities across generation, transmission, distribution and customer-centric solutions thereby building a greener and smarter tomorrow." Result PDF
Pharmaceuticals company Dr. Reddy's Laboratories announced Q4FY26 & FY26 results Consolidated Financial Highlights: Revenues for Q4FY26 stood at Rs 75,162 million, representing a decline of 13.87% QoQ from Rs 87,268 million and a decrease of 11.64% YoY from Rs 85,060 million. Gross Profit for Q4FY26 was Rs 33,691 million, a decrease of 28.02% QoQ from Rs 46,806 million and a decline of 28.72% YoY from Rs 47,263 million. Profit Before Tax for Q4FY26 was Rs 1,991 million, a significant decline of 87.10% QoQ from Rs 15,429 million and 90.07% YoY from Rs 20,054 million. Profit for the period (Net Profit) in Q4FY26 was Rs 2,205 million, reflecting a decrease of 81.46% QoQ from Rs 11,896 million and 86.11% YoY from Rs 15,873 million. EBITDA for Q4FY26 stood at Rs 9,807 million, a decline of 52.14% QoQ from Rs 20,493 million and 60.37% YoY from Rs 24,749 million. For FY26, Consolidated Revenues were Rs 3,35,933 million, a growth of 3.20% YoY compared to Rs 3,25,535 million in FY25. Annual Consolidated Profit for the year FY26 was Rs 42,466 million, a decrease of 25.82% YoY from Rs 57,245 million in FY25. Consolidated EBITDA For FY26 was Rs 76,595 million, a decrease of 16.86% YoY from Rs 92,133 million in FY25. Standalone Financial Highlights: Total Income for Q4FY26 was Rs 43,892 million, reflecting a decline of 5.47% QoQ from Rs 46,430 million and 26.57% YoY from Rs 59,773 million. Revenue from Operations for Q4FY26 stood at Rs 38,220 million, down 10.76% QoQ from Rs 42,827 million and 31.30% YoY from Rs 55,629 million. The company reported a Net Loss of Rs 2,194 million for Q4FY26, compared to a profit of Rs 906 million in Q3FY26 and a profit of Rs 12,007 million in Q4FY25. For FY26, Standalone Total Income reached Rs 2,22,224 million, a decline of 7.86% YoY compared to Rs 2,41,188 million in FY25. Annual Standalone Profit After Tax for FY26 was Rs 32,197 million, a decrease of 39.81% YoY from Rs 53,494 million in FY25. Business Highlights: Segment Performance: Global Generics: This segment reported revenues of Rs 2,99,460 million for FY26, a growth of 3% YoY. Pharmaceutical Services and Active Ingredients (PSAI): This segment reported revenues of Rs 42,672 million for FY26. Others: This segment reported revenues of Rs 2,140 million for FY26. Geographical Performance: North America: Revenues were Rs 1,13,737 million, a decline of 22% YoY, impacted by lower Lenalidomide sales and a one-time Shelf Stock Adjustment (SSA). Emerging Markets: Revenues reached Rs 67,608 million, a growth of 23% YoY. Within this, Russia revenues grew 34% YoY to Rs 34,800 million. India: Revenues stood at Rs 62,186 million, a growth of 16% YoY. Europe: Revenues reached Rs 55,501 million, reflecting a significant growth of 55% YoY. Dividend: The Board of Directors recommended a final dividend of Rs 8 per equity share of face value Rs 1 each (800% of face value) for the year ended March 31, 2026. Significant One-offs: Recorded a Shelf Stock Adjustment (SSA) related to Lenalidomide of Rs 4,530 million as a reduction of revenue. Recognized an impairment of CAR-T assets and Eftilagimod Alfa totaling Rs 2,277 million. Provisions related to a VAT liability of Rs 1,141 million were recognized. Labour Codes Impact: The company assessed the implications of the New Labour Codes and recognized an incremental cost of Rs 1,170 million towards employee benefits during FY26. Launches: Launched generic Semaglutide Injection in India under the brand name ‘Obeda’ on the first day of market formation. G V Prasad, Co-Chairman & MD, said: "Our performance this year reflects the impact of lower lenalidomide sales and several one-offs. The resilience of our branded businesses and currency tailwinds helped partially mitigate this impact. We remain focused on strengthening our base business and improving margins, through cost efficiencies and portfolio optimization. In parallel, we continue to build long-term franchises in biosimilars, consumer health and innovation to deliver sustainable value." Result PDF
Aerospace & Defence company MTAR Technologies announced Q4FY26 & FY26 results Consolidated Financial Highlights: Total Revenue from Operations: For Q4FY26, the company reported revenue of Rs 3,060.69 million, representing a growth of 10.11% QoQ from Rs 2,779.60 million in Q3FY26 and a significant increase of 67.17% YoY compared to Rs 1,830.88 million in Q4FY25. Annual Revenue: For FY26, consolidated revenue stood at Rs 8,762.06 million, a growth of 29.62% YoY compared to Rs 6,759.95 million in FY25. Total Income: Total income for Q4FY26 was Rs 3,224.64 million, up 15.02% QoQ from Rs 2,803.65 million and up 76.10% YoY from Rs 1,831.18 million. For FY26, total income reached Rs 8,992.96 million compared to Rs 6,811.45 million in FY25. Net Profit: Net profit for Q4FY26 reached Rs 442.83 million, a growth of 27.66% QoQ from Rs 346.89 million and a substantial increase of 222.71% YoY from Rs 137.22 million. Annual Net Profit: For FY26, the company reported a net profit of Rs 940.30 million, marking an increase of 77.80% YoY compared to Rs 528.87 million in FY25. Earnings Per Share (EPS): Basic and diluted EPS for FY26 stood at Rs 30.57, compared to Rs 17.19 in FY25. Standalone Financial Highlights: Total Revenue from Operations: For Q4FY26, standalone revenue was Rs 3,060.30 million, an increase of 10.12% QoQ from Rs 2,779.01 million and a growth of 67.14% YoY from Rs 1,831.00 million. Annual Standalone Revenue: For FY26, revenue stood at Rs 8,761.08 million, up 29.61% YoY from Rs 6,759.57 million in FY25. Total Income: Standalone total income for Q4FY26 reached Rs 3,225.71 million, compared to Rs 2,804.61 million in Q3FY26 and Rs 1,832.70 million in Q4FY25. Net Profit: Standalone net profit for Q4FY26 was Rs 443.37 million, reflecting a growth of 26.07% QoQ from Rs 351.68 million and an increase of 212.32% YoY from Rs 141.96 million. Annual Standalone Net Profit: For FY26, standalone profit was Rs 953.24 million, compared to Rs 538.53 million in FY25. Business Highlights: Corporate Restructuring: The company has filed a scheme with the National Company Law Tribunal for the merger of its wholly owned subsidiaries, Gee Pee Aerospace and Defence Private Limited and Magnatar Aero Systems Private Limited, into the Holding company. Auditor Appointments: The Board approved the appointment of M/s. Sagar & Associates, Cost Accountants, as Cost Auditors and M/s. Seshachalam & Co., Chartered Accountants, as Internal Auditors for a period of three financial years (2026-27 to 2028-29). Exceptional Item: The company recognized a one-time increase in provision for employee benefits amounting to Rs 37.67 million as an exceptional item due to the implementation of the New Labour Codes. Segment Performance: In accordance with Ind AS 108 "Operating Segments," the Group’s business activity falls within a single line of business segment. Result PDF
Pharmaceuticals company Neuland Laboratories announced Q4FY26 & FY26 results Consolidated Financial Highlights: Quarterly Revenue: Revenue from operations for Q4FY26 stood at Rs 77,625.03 lakh, representing a growth of 76.54% QoQ from Rs 43,970.93 lakh in Q3FY26 and a significant increase of 136.40% YoY compared to Rs 32,836.00 lakh in Q4FY25. Quarterly Total Income: Total income for Q4FY26 reached Rs 78,870.85 lakh, up 76.14% QoQ from Rs 44,776.17 lakh and up 134.86% YoY from Rs 33,582.43 lakh in Q4FY25. Quarterly Profit: Profit after tax (PAT) for Q4FY26 was Rs 21,267.26 lakh, reflecting a massive growth of 424.18% QoQ compared to Rs 4,057.19 lakh in Q3FY26 and a 664.85% increase YoY from Rs 2,780.59 lakh in Q4FY25. Annual Revenue: For FY26, revenue from operations reached Rs 2,02,298.54 lakh, marking a growth of 36.98% over Rs 1,47,683.73 lakh in FY25. Annual Total Income: Annual total income stood at Rs 2,05,315.16 lakh for FY26, compared to Rs 1,49,734.66 lakh in the previous year, showing an increase of 37.12% YoY. Annual Profit: Consolidated profit after tax for FY26 reached Rs 36,399.84 lakh, reflecting a growth of 39.94% YoY from Rs 26,010.81 lakh in FY25. Total Comprehensive Income: The group reported an annual Total Comprehensive Income of Rs 36,506.25 lakh for FY26, compared to Rs 26,006.33 lakh in FY25. Standalone Financial Highlights: Quarterly Revenue: Revenue from operations for Q4FY26 reached Rs 77,625.03 lakh, up 76.54% QoQ from Rs 43,970.93 lakh in Q3FY26 and up 136.40% YoY from Rs 32,836.00 lakh in Q4FY25. Quarterly Total Income: Total income for the quarter stood at Rs 78,870.72 lakh, an increase of 76.14% QoQ from Rs 44,776.17 lakh and an increase of 134.86% YoY from Rs 33,582.38 lakh. Quarterly Profit: Standalone profit after tax for Q4FY26 was Rs 21,252.31 lakh, reflecting a growth of 425.85% QoQ from Rs 4,041.55 lakh and a significant 666.30% increase YoY from Rs 2,773.39 lakh in Q4FY25. Annual Revenue: Annual standalone revenue from operations for FY26 was Rs 2,02,298.54 lakh, a growth of 36.98% YoY compared to Rs 1,47,683.73 lakh in FY25. Annual Profit: Standalone profit For FY26 reached Rs 36,310.50 lakh, representing a growth of 39.97% YoY from Rs 25,942.54 lakh in FY25. Business Highlights: Capacity Expansion: The Board approved an enhancement of capacity at Unit 1 located at Bonthapally Village, Sangareddy District, Telangana. The project involves a proposed capacity addition of 120.5 KL with an estimated investment of Rs 143.4 crore (including GST) to be completed within 12 to 18 months. Segment Performance: The Group has only one reportable segment, namely "manufacture of active pharmaceutical ingredients and allied services." For FY26, geography-wise revenue was distributed as follows: USA and North America at Rs 71,345.10 lakh, Europe at Rs 67,544.32 lakh, India at Rs 48,409.19 lakh, and Rest of the world at Rs 14,999.93 lakh. Dividend Recommendation: The Board of Directors recommended a final dividend of Rs 34/- (340%) per equity share of face value Rs 10 each for FY26. Board Appointment: Dr. Mauricio Futran was appointed as an Additional Director in the category of Non-Executive Non-Independent Director effective May 12, 2026. Asset Transfer: During the previous year, the company fully transferred an investment property located in Hyderabad through a perpetual lease, which resulted in a total exceptional profit of Rs 7,640.36 lakh. Subsidiary Performance: The results include the audited financial results of two subsidiaries: Neuland Laboratories K.K., Japan, and Neuland Laboratories Inc., USA. Together they reflect total assets of Rs 1,147.50 lakh as at March 31, 2026, and total revenue of Rs 2,160.07 lakh for the year. Saharsh Davuluri, Chief Executive Officer & Managing Director, Neuland Laboratories, said “We are pleased with the fact that we have ended FY26 on a strong note in line with our original expectations. There is good business visibility in the short to medium term anchored by commercial and near-commercial molecules. Our focus on execution discipline, customer satisfaction, and protection of business fundamentals is central to ensuring this phase of growth. At the same time, we are laying the groundwork for growth beyond this horizon. Key elements of this foundation are the investments in Peptide Manufacturing as well as the new R&D; Centre, which are proceeding according to plan. Our Business Development strategy is aligned to the investments and is focused on bringing in the right kind of projects that support high quality, sustainable growth.” Result PDF
Consumer Electronics company Dixon Technologies (India) announced Q4FY26 & FY26 results Consolidated Financial Highlights: Total Revenue: For Q4FY26, the company reported a total revenue (including other income) of Rs 10,59,481 lakh, representing a YoY growth of 2.82% compared to Rs 10,30,382 lakh in Q4FY25, and a QoQ decline of 1.93% from Rs 10,80,291 lakh in Q3FY26. Annual Revenue: Total revenue for the full year FY26 reached Rs 49,58,584 lakh, reflecting a significant growth of 27.53% YoY compared to Rs 38,88,033 lakh in FY25. EBIDTA: Annual EBIDTA for FY26 stood at Rs 2,58,000 lakh, registering a robust increase of 69% over Rs 1,52,800 lakh in FY25. For Q4FY26, EBIDTA was Rs 49,300 lakh, up 9% YoY from Rs 45,400 lakh. Profit Before Tax (PBT): Annual PBT grew by 32% YoY to reach Rs 2,07,056 lakh in FY26. For Q4FY26, PBT stood at Rs 36,976 lakh, representing a YoY decline of 35.81% from Rs 57,603 lakh. Net Profit (PAT): Consolidated PAT for the full year FY26 was Rs 1,64,425 lakh, marking a 33.40% YoY increase from Rs 1,23,258 lakh in FY25. For Q4FY26, PAT was Rs 29,797 lakh, a YoY decrease of 35.91% compared to Rs 46,495 lakh. Standalone Financial Highlights: Total Revenue: For Q4FY26, standalone total revenue was Rs 94,261 lakh, compared to Rs 1,12,681 lakh in Q4FY25 and Rs 98,483 lakh in Q3FY26. Annual Revenue: Standalone annual revenue for FY26 stood at Rs 4,73,246 lakh, representing a decline of 13.44% from Rs 5,46,737 lakh in FY25. Net Profit (PAT): Annual standalone PAT for FY26 reached Rs 75,944 lakh, reflecting a YoY growth of 34.20% compared to Rs 56,590 lakh in FY25. For Q4FY26, standalone PAT was Rs 7,790 lakh. Business Highlights: Dividend: The Board of Directors has recommended a final dividend of Rs 10.00/- per equity share (500%) of face value Rs 2/- each for the financial year 2025-2026. Segment Performance: Mobile & Other EMS Division: This segment reported revenue of Rs 44,25,700 lakh, representing a growth of 34% YoY. The operating profit for this division increased by 35% to Rs 1,55,300 lakh. Consumer Electronics & Appliances (LED TV & Refrigerator): This segment recorded revenue of Rs 2,89,200 lakh, a YoY decline of 19%. The operating profit stood at Rs 14,300 lakh. Home Appliances: The segment achieved revenue of Rs 1,42,600 lakh, reflecting a 4% YoY growth, with an operating profit of Rs 15,800 lakh. Strategic Transactions: Effective August 1, 2025, the company transferred its lighting business undertaking to a joint venture company, Lightanium Technologies Private Limited, for a total consideration of Rs 14,030 lakh. Acquisitions: The company acquired a 51% stake in Kunshan Q Tech Microelectronics (India) Private Limited for an aggregate cash consideration of Rs 55,300 lakh. Stock Options: The Nomination and Remuneration Committee approved the grant of 16,155 stock options to employees of the company, its subsidiaries, and joint ventures under the "Dixon ESOP 2023" plan. Working Capital: The company reported a net working capital of (8) days for FY26, compared to (5) days in FY25. Net debt as of March 31, 2026, was Rs (773) crore. Result PDF
Paints company Berger Paints (India) announced Q4FY26 & FY26 results Standalone Financial Highlights: Revenue from operations for Q4FY26 was Rs 2,504.00 crore, compared to Rs 2,595.01 crore in Q3FY26 (a decrease of 3.51% QoQ) and Rs 2,347.45 crore in Q4FY25 (an increase of 6.67% YoY). Total Income for Q4FY26 stood at Rs 2,540.15 crore, reflecting a decrease of 5.95% QoQ from Rs 2,700.73 crore in Q3FY26 and an increase of 7.32% YoY from Rs 2,366.90 crore in Q4FY25. Profit for the period (Net Profit) in Q4FY26 was Rs 327.28 crore, representing an increase of 9.69% QoQ compared to Rs 298.37 crore in Q3FY26 and an increase of 38.14% YoY compared to Rs 236.92 crore in Q4FY25. Total Comprehensive Income for Q4FY26 reached Rs 331.36 crore, showing an increase of 10.76% QoQ from Rs 299.16 crore and an increase of 40.09% YoY from Rs 236.53 crore. For FY26, standalone Revenue from operations was Rs 10,420.10 crore, an increase of 2.47% YoY from Rs 10,169.22 crore in FY25. Annual Standalone Total Income for FY26 was Rs 10,612.97 crore, a 3.12% increase over Rs 10,291.43 crore in FY25. Annual Standalone Net Profit for FY26 stood at Rs 1,095.66 crore, growing by 1.69% YoY compared to Rs 1,077.50 crore in FY25. Basic Earnings Per Share (EPS) for FY26 was Rs 9.40, up from Rs 9.24 in FY25. Consolidated Financial Highlights: Revenue from operations for Q4FY26 was Rs 2,868.03 crore, representing a decrease of 3.89% QoQ from Rs 2,983.97 crore in Q3FY26 and an increase of 6.07% YoY from Rs 2,704.03 crore in Q4FY25. Total Income for Q4FY26 was Rs 2,889.74 crore, reflecting a 4.14% decline QoQ from Rs 3,014.50 crore in Q3FY26 and a 6.19% increase YoY from Rs 2,721.14 crore in Q4FY25. Profit for the period (Net Profit) in Q4FY26 was Rs 335.25 crore, reflecting an increase of 23.55% QoQ from Rs 271.35 crore in Q3FY26 and an increase of 27.52% YoY from Rs 262.91 crore in Q4FY25. Total Comprehensive Income for Q4FY26 was Rs 351.39 crore, up by 24.43% QoQ from Rs 282.43 crore and up by 38.40% YoY from Rs 253.89 crore. For FY26, consolidated Revenue from operations was Rs 11,880.25 crore, an increase of 2.91% YoY compared to Rs 11,544.71 crore in FY25. Annual Consolidated Total Income for FY26 reached Rs 11,986.95 crore, up 2.99% YoY from Rs 11,639.49 crore. Annual Consolidated Net Profit for FY26 was Rs 1,128.02 crore, a decrease of 4.63% YoY from Rs 1,182.81 crore in FY25. Basic Earnings Per Share (EPS) for FY26 was Rs 9.67, compared to Rs 10.13 in FY25. Business Highlights: Dividend: The Board of Directors recommended a dividend of Rs 4.00 (400%) per equity share of face value of Re 1/- each for FY26. Segment Performance: The company is primarily engaged in the "Paints and Coatings" business. In accordance with Ind AS 108 - Operating Segments, there are no separate reportable segments. Operational Growth: Standalone operations achieved a volume growth of 11.8% during the quarter despite challenging market conditions. Automotive and Industrial Performance: The automotive segment showed strong performance due to CST cuts and lower financing costs. The General Industrial segment also reported healthy growth. New Launch: The company launched "Kolor Plus" in the premium emulsion segment, which received a heartening market response. Subsidiaries & JVs: Bolix SA, Berger Becker Coatings, Berger Nippon, and Berger Rock delivered strong double-digit growth in both topline and operating profit. SBL Specialty Coatings Private Limited registered moderate growth. Nepal Operations: Performance in Nepal remained impacted by the unstable political scenario and elections. Inorganic Growth: In April 2024, Bolix S.A. (a step-down subsidiary) acquired the remaining 25% stake in Surefire Management Services Limited (SMSL), making it a 100% wholly-owned subsidiary. Abhijit Roy, Managing Director & CEO, Berger Paints India, said: "The progressive demand improvement seen in the previous quarter continued into the 4th quarter which enabled the achievement of a healthy volume growth of 11.8% for the quarter. This growth was supported by a qualitative improvement in mix and softening of raw material prices resulting in a 10-quarter high Gross Margin and Operating Profit Margin. We continued to register healthy and robust growth in our key focus segments of waterproofing, construction chemicals and wood coatings. The positive market response to our new launch "Kolor Plus" in the premium emulsion segment is very heartening. Our efforts in network expansion and improving growth in low market share Urban markets continue to show positive uptick ,nonth on month leading us to being hopeful of improved results going forward. The automotive segment performed strongly following the increased demand post CST cuts and lower financing costs. This was closely followed by the General Industrial segment which also saw good growth. . Protective and Powder Coatings registered improvements month on month indicating a recovery in growth levels towards the end of the quarter. Our subsidiaries & IVs like Bo/ix SA, Berger Becker Coatings, Berger Nippon & Berger Rock delivered strong double-digit growth in both topline and operating profit. SBL Specialty Coatings Private Limited registered moderate revenue and profit growth for the quarter. Our Nepal operations peiformance remained impacted by the unstable political scenario & elections there which is expected to now improve with the changed scenario. STP Limited topline remained impacted resulting in a muted operating profitability due to scale. The gradual improvement in domestic demand indicators across segments and markets, the sequential monthly uptick in demand are all positive indicators and results in the months ahead are expected to reflect these movements. The calibrated price increases of over 11% initiated in a staggered manner from end March'26 is expected to support the Gross Margin amid rising raw material cost. Forex volatility and geopolitical uncertainty continue to pose near-term margin risks on both supply disruptions and raw material inflation. At Berger Paints our efforts will remain focused on network expansion, product & service innovation and brand building aimed at improving value for our investors and stakeholders." Result PDF